Coronary interventions Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions Kelbæk H, Yeh R, Engstrøm T, Neumann F-J, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S November 20, 2019 | 10.4244/EIJ-D-19-00866
Coronary interventions Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial Fajadet J, Neumann F-J, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S January 20, 2017 | 10.4244/EIJV12I13A262
Coronary interventions Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program Di Mario C, Serruys P, Silber S, Lu S, Wang W, Widimsky P, Xu B, Windecker S November 20, 2016 | 10.4244/EIJV12I10A199
Coronary interventions Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program Abdel-Wahab M, Neumann F-J, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G July 20, 2016 | 10.4244/EIJY15M07_07
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions Kelbæk H, Holmvang L, Richardt G, Eberli F, Stella P, Buszman P, Neumann F-J, Serruys P, Windecker S, Widimsky P, Belardi J, Silber S October 20, 2015 | 10.4244/EIJY14M07_14
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P September 22, 2015 | 10.4244/EIJY14M12_13
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention Vranckx P, Kalesan B, Stefanini GG, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys P, Windecker S June 19, 2015 | 10.4244/EIJV11I2A31
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment Stella P, Belkacemi A, Waksman R, Stahnke S, Torguson R, Von Strandmann R, Agostoni P, Sangiorgi G, Silber S October 28, 2011 | 10.4244/EIJV7I6A113
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial Silber S, Gutiérrez-Chico J-L, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Nienaber C, Naber C, Chevalier B, Serruys P May 17, 2011 | 10.4244/EIJV7I1A13
Clinical results after coronary stenting with the GenousTM Bio-engineered R stentTM: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry Silber S, Damman P, Klomp M, Beijk M, Grisold M, Ribeiro E, Suryapranata H, Wójcik J, Sim K, Thijssen J, de Winter R February 21, 2011
Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity Vranckx P, Cutlip D, Mehran R, Kint P-P, Silber S, Windecker S, Serruys P February 25, 2010
Transferability of data between different drug-eluting stents Magro M, Onuma Y, Silber S, Serruys P November 15, 2009 | 10.4244/EIJV5I5A85
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007 Daemen J, Simoons M, Wijns W, Bagust A, Bos G, Bowen J, Braunwald E, Camenzind E, Chevalier B, Di Mario C, Fajadet J, Gitt A, Guagliumi G, Hillege H, James S, Jüni P, Kastrati A, Kloth S, Kristensen S, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys P, Silber S, Steg P, Tariah I, Wallentin L, Windecker S January 20, 2009
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™ Duckers H, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys P November 20, 2007
'Fused-Gold' vs. 'Bare' stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP Study Fort S, Kornowski R, Silber S, Lewis B, Bilodeau L, Almagor Y, van Remortel E, Morice M, Colombo A August 20, 2007
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent Duckers H, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys P May 22, 2007
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D February 20, 2007
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019